Flagship unwraps new AI biotech that looks to predict variants before they're here - Endpoints News

While Moderna is testing Omicron-specific boosters for this fall, its investor Flagship Pioneering is building a biotech that says it uses AI to predict virus variants prior to outbreaks. Apriori Bio, derived from the Latin phrase a priori that translates to

While Mod­er­na is test­ing Omi­cron-spe­cif­ic boost­ers for this fall, its in­vestor Flag­ship Pi­o­neer­ing is build­ing a biotech that says it us­es AI to pre­dict virus vari­ants pri­or to out­b… [+2716 chars]

full article...